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TNF production by the medullary thick ascending limb of Henle's loop.
Medullary thick ascending limb of Henle's loop (mTALH) tubules,
isolated from kidneys of male Sprague-Dawley rats, expressed the gene
for tumor necrosis factor (TNF) and released this cytokine when
challenged with lipopolysaccharide (LPS). The TNF produced was
biologically active, as determined by cytotoxic activity present in
supernatants from LPS-stimulated mTALH, using the TNF-sensitive
murine fibrosarcoma cell line, WEHI 164. The amount of TNF pro-
duced, approximately 75 nM, has previously been shown to affect ion
transport in the mTALH. The TNF-mediated cytotoxicity (and ion
transport effects) were completely neutralized with a polyclonal anti-
TNF antisera. Further, immunoprecipitation experiments demon-
strated that the 17 kDa TNF monomer was formed by de novo protein
synthesis. In contrast, the mTALH did not produce the related cyto-
kine, lymphotoxin (LT). Production of TNF was confirmed by demon-
strating the accumulation of a 1.6 kb TNF mRNA by Northern blot
analysis; mRNA for LT was not detected. Expression of the TNF gene
in the mTALH was confirmed by the polymerase chain reaction (PCR).
Southern blot analysis and ethidium bromide staining of the resultant
PCR products revealed the expected 276 bp sequence of TNF DNA for
the mTALH. We have demonstrated that mTALH tubules stimulated
with LPS express the gene for TNF, but not LT, and release biologi-
cally active TNF. TNF is an important mediator of septic shock and
may contribute to changes in renal function associated with endotox-
emia. Production of TNF by the mTALH may be an important
autocrine regulatory mechanism for this nephron segment.
Tunor necrosis factor-alpha (TNF) is a cytokine that has
both protective and pathophysiological effects in vivo. For
example, TNF has a protective role in bacterial and parasitic
infections, but contributes to the immune and inflammatory
events associated with graft versus host reactions, experimental
allergic encephalomyelitis, delayed-type hypersensitivity reac-
tions, and autoimmune diseases [1]. TNF has also been impli-
cated as an important mediator of cachexia and endotoxemia.
Although macrophages and T cells are the major cellular
sources of TNF, there is increasing evidence of TNF produc-
tion by non-immune cells. For example, renal production of
TNF has been demonstrated in proximal tubules [2] and me-
sangial cells [3], and astrocytes also have been shown to
produce TNF [4]. Further, lipopolysaccharide (LPS)-stimulated
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proximal tubular epithelial cells express both the membrane-
associated and secreted forms of TNF [5].
TNF mRNA expression increased to a greater extent in the
kidney, compared to other organs, after in vivo administration
of endotoxin [6]. Further, increased release of TNF, and a
positive correlation in serum concentrations of TNF to blood
urea nitrogen and creatinine levels, were observed in an in viva
renal ischemialreperfusion injury model [7]. The resultant de-
crease in renal function was attributed to increased TNF
production by infiltrating neutrophils during the reperfusion
period. However, it is conceivable that both infiltrating immune
cells and renal cells could have contributed to the observed
effects by producing TNF.
The medullary thick ascending limb of Henle's loop
(mTALH) transports 25% of the filtered load in the kidney. It
also regulates medullary interstitial osmolality, which is essen-
tial for the preservation of the renal counter-current exchange
system and the ability of the kidney to produce either a
hyperosmotic or hypo-osmotic urine. Thus, changes in the
integrity/function of this tubular segment during inflammation
could have significant effects on regulation of blood pressure
and extracellular fluid volume. The mTALH also may be an
important renal immunoregulatory site since cytokines, such as
TNF and IL-l, bind to the Tamm-Horsfall glycoprotein, an
immunosuppressive cell-specific marker present on the apical
and basolateral membranes of the mTALH [8]. Furthermore,
cytokines such as TNF, IL-i, and interferon-gamma induce the
expression of cell adhesion molecules on endothelial and tubu-
lar epithelial cells [9].
Renal cyclooxygenase metabolizes arachidonic acid (AA) to
several metabolites, including prostaglandin E2 (PGE2), that
affect renal blood flow, glomerular filtration rate, and ion
transport in the kidney. Interestingly, cytokines can affect
epithelial ion transport through the induction of AA metabolites
[10, 11]. Further, addition of exogenous TNF to cultured
mTALH cells inhibits ion transport by a prostaglandin-depen-
dent mechanism, suggesting that TNF could act as a paracrine
regulator of ion transport in the mTALH [12]. In this study, we
demonstrated expression of the TNF gene, accumulation of
TNF mRNA, and subsequent TNF production by the mTALH
in response to LPS stimulation. Thus, TNF also may act in an
autocrine manner to affect ion transport in this nephron seg-
ment.
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Methods
Animals
Male Sprague-Dawley rats (Charles River Lab, Wilmington,
Massachusetts, USA) weighing 300 to 325 g (9 weeks old) were
maintained on standard rat chow (Ralston-Purina Co., Chicago,
Ilinois, USA) and given tap water ad libitum.
Reagents
Tissue culture media, collagenase, and streptavidin agarose
beads were obtained from Gibco (Grand Island, New York,
USA), chemicals were from Sigma (St. Louis, Missouri, USA).
Guanidine isothiocyanate was purchased from Fluka
(Ronkonkama, New York, USA), 35S-methionine/35S-cysteine
and GeneScreen were from NEN Dupont (Boston, Massachu-
setts, USA), and biotinylated goat anti-rabbit IgG was obtained
from Pierce (Rockford, Illinois, USA). AMPLIFY® and 14C-
methylated molecular mass markers were purchased from Am-
ersham (Arlington Heights, Illinois, USA). The vector pGEM4
was obtained from Promega (Madison, Wisconsin, USA), and
the GeneAmp® RNA PCR kit was purchased from Perkin Elmer
Cetus (Norwalk, Connecticut, USA). Sense and anti-sense
primers were obtained from Stratagene (La Jolla, California,
USA).
Isolation of mTALH tubules
The mTALH were isolated as previously described [12—141.
Briefly, male Sprague-Dawley rats were anesthetized with an
intraperitoneal injection of pentobarbital (0.65 mgJlOO g body
wt). The kidneys were perfused with sterile 0.9% saline, via
retrograde perfusion of the aorta, and cut along the corticopap-
illary axis. The inner stripe of the outer medulla was excised,
minced with a sterile blade, and incubated for 10 minutes at
37°C in a 0.75% coliagenase solution gassed with 95% oxygen.
The suspension was sedimented on ice, and the supernatant
containing the crude suspension of tubules was collected. The
collagenase digestion was repeated with the remaining undi-
gested tissue. The combined supernatants were spun, resus-
pended in Hank's buffer, and filtered through a 52 m nylon
mesh (Fisher Scientific, Springfield, New Jersey, USA). The
filtrate was discarded, and the tubules retained on the mesh
were resuspended in Dulbecco's modified eagle's medium
(DMEM; Gibco, Grand Island, New York). Combination of the
perfusion and size exclusion steps was done to eliminate blood
elements that produce TNF from the preparation [13, 14].
Immunohistochemical identification of the Tamm-Horsfall
glycoprotein
Tubules were resuspended in 1 ml of Dulbecco's modified
Eagle's medium (DMEM)-containing 10 m HEPES (pH 7.4;
Sigma), and goat anti-human uromucoid antiserum (1:50)
(Tamm-Horsfall glycoprotein; Cappel), and incubated for 20
minutes on ice, washed twice with phosphate-buffered saline
(PBS), and resuspended in 1 ml of PBS. Aliquots of the tubule
suspensions were washed, and then incubated for 30 minutes at
4°C with affinity-purified donkey anti-goat IgG (1:250) labeled
with fluorescein isothiocyanate (FITC). The tubules were
washed, resuspended in DMEM, and examined by fluorescence
microscopy. Control samples were incubated with whole goat
serum, or FITC-labeled anti-goat IgG in the absence of goat
anti-human uromucoid antiserum.
Alkaline phosphatase assay
Alkaline phosphatase activity was determined by measuring
the hydrolysis of p-nitrophenylphosphate. Activity was as-
sessed in tissue homogenates obtained from undigested outer
medulla and isolated mTALH tubules prepared in 0.01 M Tris
containing 0.25 M sucrose, pH 7.4. Liver and renal cortical
homogenates were used as negative and positive controls,
respectively. Preliminary kinetic experiments ensured that the
formation of p-nitrophenoi from p-nitrophenyiphosphate by
each tissue was linear for 30 minutes. An aliquot of homoge-
nized tissue, containing 50 g of protein, was incubated for 30
minutes at 37°C in a substrate buffer (pH 10.5) containing 0.1 M
glycine and 1 m MgCl2. The reaction was stopped with 50 mM
NaOH, and the absorbance was measured at 405 nm. Protein
concentration was determined using the Bradford assay [15].
Oxygen consumption
The oxygen consumption of freshly isolated mTALH tubules
resuspended in DMEM was measured with a Clark-type elec-
trode (Instech, Plymouth Meeting, Pennsylvania) inserted into
a 0.3 ml temperature controlled (37°C) chamber (YSI, Yellow
Springs, Ohio, USA). The amount of tubules (protein) added
was titrated so that all the oxygen in the chamber was con-
sumed in 30 minutes. The change in oxygen concentration in the
chamber was monitored on a Soitec recorder. A constant slope
was established during a control period, and additions to the
chamber were made in volumes that did not exceed 1% of the
volume of the measuring chamber. The rate of oxygen con-
sumption was determined from the slope of the recorded curve,
by measuring its angle against the vehicle oxygen consumption
slope and calculating the tangent [14]. Results are expressed as
nmoles of oxygen utilized/mm/mg of tissue.
Bioassay for TNF
TNF bioactivity was measured as previously described [16]
using the WEHI-164 fibrosarcoma cell line, which is sensitive
and specific to the cytotoxic effects of TNF and lymphotoxin
(LT). Serial dilutions of the supernatants derived from the
mTALH tubules (0.5 g wet wt) were incubated with 5 X
WEHI-164 cells in 96-well microtiter plates for 48 hours at
37°C/5% CO2. Cell viability was determined by the addition of
3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT), a tetrazolium ring-containing compound which is
cleaved by dehydrogenases of active mitochondria. Five mg/mi
MTT was added to each well and incubated for four hours at
37°C/5% CO2. One hundred microliters of 0.04 N HC1 in
isopropanol was added to each well, and plates were read using
a test wavelength of 570 nm and a reference wavelength of 630
nm. One unit of bioactivity is defined as the supernatant dilution
at which 50% cytotoxicity is observed. Recombinant murine
TNF was used as a positive control.
Immunoprecipitation
mTALH tubules (0.5 g wet wt) were incubated with or
without LPS in methionine-free DMEM in the presence of 200
CiJmi of 35S-methionine/35S-cysteine for 20 hours. Samples
were spun and the pellets containing the tubules were lysed in
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PBS containing 1% Triton X-100 and 0.1% BSA. The lysed
tubules, and the supernatants were pre-cleared with preimmune
rabbit sera for one hour on ice. Samples were then incubated for
two hours with biotinylated goat anti-rabbit IgG (50 jsg/ml).
Samples were washed and streptavidin agarose beads were
added to the samples, which were mixed by inversion for 30
minutes. Samples were then spun and the supernatants were
incubated for two hours with a 1:50 dilution of a rabbit
polyclonal antisera against murine TNF [161. These antisera
inhibited the cytotoxic effects of mouse and human rTNF, and
also inhibited TNF and LT produced by the munne T cell clone,
P1.28. Antibody-antigen complexes were precipitated for two
hours with biotinylated goat anti-rabbit IgG and streptavidin
agarose as the solid matrix. The immunoprecipitates were
washed with 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS, and 0.1% ovalbumin in PBS and electrophoresed on
a 15% acrylamide SDS-PAGE gel. The gels were treated with
AMPLIFY®, dried by vacuum and exposed to Kodak X-Omat
film with intensifier screens at —70°C. 14C-methylated molecu-
lar mass markers were used as a standard and included the
following proteins: myosin (200 kDa), phosphorylase b (97.4
kDa), BSA (69 kDa), ovalbumin (46 kDa), carbonic anhydrase
(30 kDa), and lysozyme (14.3 kDa).
cDNA probes
A 1.4 kB murine TNF cDNA probe (a gift from Dr. Bruce
Beutler, University of Texas Southwestern Medical School,
Dallas, Texas, USA) was excised from the BamHl and Pstl
sites of the vector pGEM4. A 0.71 kB Kpnh/HincII fragment of
the murine LI cDNA was used as the LI probe [17].
Isolation of total RNA/Northern blot analysis
Total RNA was isolated by lysing the tubules in guanidine
isothiocyanate/Na-citrate buffer followed by ethanol precipita-
tion. Briefly, cells were lysed with guanidine isothiocyanate,
passed vigorously through a 27 gauge needle, and incubated for
30 minutes with 100% ethanol (0.5 vol). Samples were spun at
12,000 x g, 4°C, supernatants were aspirated and the pellets
resuspended in guanidine isothiocyanate. RNA was precipi-
tated with ice-cold 100% ethanol and the pellets were succes-
sively washed with 70% ethanol and 100% ethanol. RNA
samples were stored at —70°C as ethanol precipitates. Ten
micrograms of total total RNA was electrophoresed in a 1%
agarose/formaldehyde gel in lx MOPS as the running buffer, as
previously described [18]. RNA was then transferred to a nylon
membrane (GeneScreen) and hybridized to random-primed
32P-labeled probes in a buffer containing 50% formamide, 10%
dextran sulfate, 0.2% polyvinylpyrrolidone, 0.2% Ficoll, 0.2%
BSA, 1.0 M NaC1, 1.0% SDS, 0.05 M Tris pH 7.5, and 0.1%
sodium pyrophosphate at 4°C for 18 hours. Post-hybridization
washes of the membrane were carried out in 2x SSC, 1.0% SDS
at 65°C for one hour and in 0.1 x SSC at 25°C for one hour. Then
the probed blots were exposed at —70°C to Kodak X-Omat film.
Polymerase chain reaction
A 1 pg aliquot of total RNA isolated from unstimulated or
LPS-stimulated mTALH tubules was used for cDNA synthesis
using the GeneAmp RNA PCR kit in a 20 d reaction mixture
containing cloned Moloney Murine Leukemia Virus reverse
transcriptase (2.5 U/jsl), RNase inhibitor (1 U/pi), and random
hexamers (2.5 jsM). The reaction mixture was incubated at
room temperature for 10 minutes to allow extension of the
primers by reverse transcriptase, and then at 42°C for 15
minutes, 99°C for five minutes, and 4°C for five minutes. An
aliquot of the cDNA was then amplified using Amplitaq DNA
polymerase (0.025 U/pi) in the presence of the sense primer
(+412 to +432; + 177; ATGAGCACAGAAAGCATGATC) and
the antisense primer (+412 to +432; TACAGGC1TGTCACTC-
GAATF) for mouse TNF which were used at a final concentra-
tion of 1 pM. The amplification (30 cycles) was initiated by one
minute of denaturization at 94°C, two minutes of annealing at
58°C, and polymerization for three minutes at 72°C followed by
autoextension at 72°C for five minutes. The amplified product
was then analyzed by Southern blot analysis following electro-
phoresis through a 1.5% agarose gel, transfer to nitrocellulose,
hybridization with a 32P-labeled cDNA probe for TNF and
exposure to Kodak X-Omat ifim at —70°C.
Results
Characteristics of freshly isolated mTALH tubules
Rat mTALH tubules were isolated by excision of the inner
stripe of the outer medulla, followed by enzymatic digestion
and sieving [12—14]. This combination of techniques yielded a
homogeneous (>95%) tubular suspension with long and well-
defined tubules, which expressed the Tamm-Horsfall glycopro-
tein (Fig. 1). Little or no fluorescence was observed in tubules
stained with whole goat serum and FITC-labeled rabbit anti-
goat IgG, or with FITC-labeled rabbit anti-goat IgG added in the
absence of goat anti-human Tamm-Horsfall glycoprotein. These
data indicate that non-specific staining was minimal for the
reagents used in these experiments.
TNF production by proximal tubules has been reported [2,
19]. Therefore, we measured alkaline phosphatase activity, a
membrane marker of proximal tubules, to assess proximal
tubule contamination as a possible source of TNF production.
Alkaline phosphatase activity of the isolated mTALH was ten
times less than for renal cortical homogenates (0.37 0.09 vs.
3.55 0.28 nmollmllmin, respectively; Fig. 2). The activities of
medullary and liver homogenates were 0.83 0.27 versus of
0.22 0.02 nmollmllmin, respectively. Thus, activity of the
isolated mTALH was similar to that of the liver homogenates
(negative control). This suggests that the presence of proximal
tubules was negligible, and confirms previous assessments of
mTALH purity [121.
The NaKtATPase accounts for approximately 40 to 50%
of the oxygen consumption by the mTALH [201. Since high
Na-K-ATPase activity in the mTALH is characteristic of this
nephron segment, ouabain-sensitive oxygen consumption was
assessed in the mTALH tubule preparation to determine if this
functional parameter was intact. Addition of ouabain (1 mM),
and determination of the slope of oxygen consumption revealed
approximately a 42% decrease in oxygen consumption, indicat-
ing that an important mechanism regulating ion transport was
retained by the freshly isolated tubules (Fig. 3A). The function-
ality of the Na-K-2Cl cotransporter, a specific marker for
the mTALH, also was assessed. Thus, addition of furosemide
(0.1 mM), an inhibitor of the cotransporter, decreased oxygen
consumption by approximately 29%. These data are similar to
Fig. 1. Immunofluorescent staining of the
Tamm-Horsfall glycoprotein. (A) mTALH
tubules were incubated with goat anti-human
uromucoid antiserum (Tamm-Horsfall
glycoprotein) for 20 minutes on ice. The
tubule suspensions were washed, and then
incubated for 30 minutes at 4°C with FITC-
labeled, affinity-purified donkey anti-goat IgG.
The tubules were washed and resuspended
with DMEM, and examined by light (left
panels) and fluorescence (right panels)
microscopy (Magnification lOOX). Control
samples were incubated with (B) whole goat
serum and FITC-labeled anti-goat IgG, or (C)
FITC-labeled anti-goat lgG in the absence of
the primary antibody.
those previously reported [141, and suggest that the Na-K-
2C1 cotransporter was functional in the freshly isolated
mTALH tubule preparation (Fig. 3B).
TNF production by mTALH tubules
Tubules were incubated for 3, 6, 9, and 24 hours in the
absence or presence of 1 gIml LPS, and TNF bioactivity was
measured using cell-free supernatants that were incubated with
WEHI-164 cells for 48 hours. Cytotoxicity, indicative of TNF
and/or LT activity, was observed at each of the time points and
was maximal at 24 hours. Serial dilutions of the 24 hour
supernatants showed significantly higher cytotoxic activity in
the LPS-stimulated mTALH compared to unstimulated
mTALH (Fig. 4). Additionally, the concentration of TNF was
estimated to be approximately 75 n, by extrapolating from a
standard curve constructed using recombinant murine TNF. It
should be noted that TNF production by cultured mTALH cells
was estimated to be 5 nM [12]. Further, the levels of TNF
production by LPS-stimulated mTALH tubules and cultured
mTALH cells are in accordance with those shown to inhibit ion
transport in the mTALH [12]. To verify that the observed
cytotoxicity was TNF-mediated, serial dilutions of the super-
natants were pre-incubated with a polyclonal anti-human TNF
antibody prior to incubation with WEHI-l64 cells. In the
presence of antibody, cytotoxicity was completely eliminated
(Fig. 5). Thus, the cytotoxic effects observed using superna-
tants from LPS-stimulated mTALH tubules were due to pro-
duction of TNF and/or LT.
De novo synthesis of TNF
We metabolically radiolabeled the mTALH with 35S-cys-
teine/35S-methionine in the absence or presence of LPS, to
ensure that the TNF detected by bioassay was synthesized and
released by the mTALH, and was not released from TNF
binding sites on the mTALH. The radiolabeled samples were
immunoprecipitated using a polyclonal anti-TNF antibody and
then separated by SDS-PAGE under reducing conditions. De
novo synthesis of the 17 kDa TNF monomer was observed for
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Fig. 2. Alkaline phosphatase activity of the isolated mTALH versus
renal cortical homogenates. Alkaline phosphatase activity was deter-
mined spectrophotometrically by measuring the hydrolysis of p-nitro-
phenylphosphate. The activity of medullary tissue and liver homoge-
nates served as negative controls. The data represent the mean SD of
4 separate experiments.
LPS-stimulated mTALH tubules, as well as supernatants from
LPS-stimulated mTALH (Fig. 6). Smaller amounts of TNF
were detected in the unstimulated mTALH. LT, which is
structurally and functionally related to TNF, was not detected
by immunoprecipitation experiments, suggesting that LPS-
stimulated mTALH produced TNF, but not LT, by de novo
protein synthesis.
Accumulation of TNF mRNA
Production of TNF by the mTALH was confirmed by dem-
onstrating the presence of the mRNA for TNF by Northern blot
analysis. Total RNA was isolated from mTALH tubules stim-
ulated with LPS for 24 hours. RAW 264 cells, a murine
macrophage cell line which produces TNF when stimulated
with LPS, were used as a positive control. Accumulation of the
1.6 kb mRNA for TNF was observed in the RAW 264 cells and
the LPS-.stimulated mTALH, but not in the unstimulated
mTALH (Fig. 7). The additional band observed for RAW 264
cells may be explained by several possible mechanisms includ-
ing: a different start site for transcription, or differential mRNA
splicing. We also determined if LT mRNA could be detected in
LPS-stimulated mTALH tubules, since this lymphokine also
has cytotoxic effects against the WEHI-164 target cell line.
Northern blot analysis was performed using an LT cDNA probe
on RNA extracted from mTALH tubules and from Fl .28 cells,
a T cell clone that produces LT when stimulated with anti-CD3
antibody. Accumulation of the 1.5 kB mRNA for LT was
demonstrated for stimulated Fl .28 cells, but not for RAW 264
cells or the mTALH (Fig. 8). These data demonstrate that the
mTALH does not transcribe the gene for LT, and support the
conclusion from immunoprecipitation experiments that the
mTALH produces TNF, but not LT. Thus, all of the cytotoxic
activity present in supernatants from LPS-stimulated mTALH,
that was neutralized with anti-TNF antibody, was due to TNF.
TNF gene transcription
The presence of the TNF gene in LPS-stimulated mTALH
tubules was determined using the polymerase chain reaction
(PCR). The resultant PCR products were separated on a 1.5%
agarose gel, transferred to nitrocellulose, and Southern blot
analysis was performed using a 32P-labeled TNF cDNA probe.
Raw 264 cells were used as a positive control, and RNA from
the pAW1O9 plasmid was used as a negative control, to ensure
that the TNF cDNA probe recognized only sequences of the
TNF gene. The 276 bp fragment of TNF DNA was observed for
RAW 264 cells and mTALH, but not for pAW1O9, by Southern
analysis, thus verifying the presence of the TNF gene in the
mTALH (Fig. 9A). Ethidium bromide staining also revealed the
presence of the predicted 276 bp fragment of TNF DNA for
RAW 264 cells and the mTALH (Fig. 9B).
Discussion
We have demonstrated that the mTALH segment of the
nephron can produce and release biologically active TNF in
response to LPS stimulation. TNF bioactivity was assessed
using the WEHI-164 bioassay, and cytotoxicity was signifi-
cantly higher in LPS-stimulated compared to unstimulated
mTALH. Furthermore, cytotoxicity was completely eliminated
in the presence of a polyclonal anti-TNF antiserum, which can
neutralize biologically active TNF and LT. Metabolically radi-
olabeled mTALH incubated in the presence of LPS produced
TNF, but not LT, by de novo synthesis. These experiments
were performed to ensure that the TNF detected by bioassay
was synthesized by the mTALH, and to determine whether the
mTALH produced LT, which cannot be distinguished from
TNF in the bioassay. The 17 kDa TNF monomer was observed
for lysed tubules and supernatants obtained from LPS-stimu-
lated mTALH. Thus, the mTALH released biologically active
TNF after it was produced and also may have expressed a
membrane-bound form of TNF, as described for other cell
types [211. A lesser amount of TNF also was detected in the
unstimulated mTALH. This may represent a low basal produc-
tion of TNF or may be the result of minimal amounts of LPS
contamination. In contrast, LT production was not detected by
immunoprecipitation, suggesting that all of the cytotoxic activ-
ity present in supernatants from LPS-stimulated mTALH was
due to TNF, and not LT. Transcription of the TNF gene in
LPS-stimulated mTALH was confirmed by assessing the accu-
mulation of mRNA for TNF by Northern blot analysis. The
WEHI-l64 cell line cannot differentiate between TNF and LT,
nor is there an available antibody which can distinguish be-
tween the two. Thus, accumulation of mRNA for LT also was
assessed. Accumulation of the 1.6 kb mRNA for TNF was
observed in the LPS-stimulated mTALH and RAW 264 cells,
but was not detected in the unstimulated mTALH. In contrast,
Northern blot analysis using a cDNA probe for LT demon-
strated accumulation of the 1.5 kB mRNA for LT in stimulated
Fl.28 cells (a T cell clone that is positive for LT when
stimulated with anti-CD3 antibody), but not in the LPS-stimu-
lated RAW 264 cells or the mTALH. Thus, the Northern blot
analyses confirm the data from immunoprecipitation experi-
ments, and support the conclusion that LPS-stimulated mTALH
oC.—wE
zE
4
3
2
0
0
0.
0)
E
E
0
0
E
Fig. 3. Oxygen consumption by mTALH
tubules. Isolated mTALH tubules were
incubated with (A) ouabain (1 mM), or
(B) furosemide (0.1 mM) at 37°C in a closed
chamber, and oxygen content was monitored
continuously as described in Methods. Oxygen
consumption is expressed as nmol 02
consumed/mm/mg protein, and the data
represent the mean + SE, n = 7. Data were
analyzed by a paired Student's t-test, * J <
0.01, ** < 0.001.
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produced TNF, but not LT. Finally, the presence of the TNF
gene product was confirmed by PCR, which was used to
amplify the predicted 276 bp fragment of the TNF eDNA. The
276 bp fragment was observed in the LPS-stimulated mTALH
and the RAW 264 cells.
TNF production resulting from LPS-stimulation of the
mTALH may have significant implications related to mTALH
function. The mTALH maintains the high medullary interstitial
osmolality necessary for the maintenance of the renal counter-
current exchange system. Further, alterations in the capacity of
the mTALH to absorb electrolytes independent of water have
significant effects on the regulation of extracellular fluid vol-
75.
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ume, and there is evidence that TNF may be an important
mediator/modulator of these mechanisms. For example, sub-
lethal doses of TNF administered to dogs caused a marked
polyuria and natriuresis [22]. Indeed, an alteration in ion
transport mediated by TNF produced by the mTALH could
lead to a natriuretic state, as well as a loss in the hypertonic
gradient essential for water reabsorption [22].
TNF has been implicated as one of the major pathological
mediators during endotoxemia [23]. This is supported by evi-
dence that TNF levels rise significantly during endotoxemia,
and that anti-TNF antibodies have been shown to prevent the
toxic effects of gram-negative bacteria. An increase in the
production of prostaglandins during septic shock also may
mediate some of the symptoms of septicemia. For example,
administration of indomethacin to TNF-treated rats prevented
the toxic effects associated with shock [24]. In fact, TNF has
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Fig. 5. Neutralization of TNF bioactivity. mTALH tubules were incu-10 40 160 640 2560 10240 bated with LPS for 24 hours. Supernatants were harvested and pre-
incubated with either polyclonal anti-TNF antibody (0), or isotype
1/Dilution control () prior to determination of TNF bioactivity (N =4).
Fig. 4. TNF production by the mTALH. mTALH tubules were incu-
bated in the presence () or absence (0) of LPS for 24 hours.
Supernatants were harvested and TNF bioactivity was determined
using the WEHI-164 cell line. The figure is representative of four similar
experiments.
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Fig. 8. Accumulation of LT mRNA. mTALH tubules were incubated
in the presence or absence of LPS for 24 hours, total RNA was analyzed
by Northern blot analysis using a radiolabeled cDNA probe for LT.
RAW 264 cells were used as a negative control, and Fl.28 T cells
stimulated with anti-CD3 antibody were used as a positive control. This
is a representative figure from four separate experiments.
uptake was diminished by treatment with indomethacin [12].
Exogenous TNF, as well as mTALH-derived TNF formed after
challenge with LPS, inhibited 86Rb uptake via a prostaglandin-
17 kD dependent mechanism. In each case, the concentrations of14.3 . a PGE2 were significantly higher in the LPS-stimulated mTALH
compared to unstimulated mTALH [12]. Thus, the effect of
TNF on ion transport in the mTALH may be related to
induction of cyclooxygenase, with subsequent PGE2 synthesis.
In fact, PGE2 has been found to directly inhibit NaC1 reabsorp-
tion in cultured mTALH cells and in rat mesangial cells, and
medullary interstitial NaC1 concentrations were increased by
inhibition of prostaglandin synthesis [25, 31, 32]. Production of
TNF by the mTALH and the effects of TNF on mTALH
function suggest that TNF may act in an autocrine manner to
affect ion transport in the mTALH via a prostaglandin-depen-
dent mechanism. The concentration of TNF produced by
mTALH tubules was approximately 75 flM. This was similar to
the concentration of TNF produced by cultured mTALH cells
which produced approximately 5 flM TNF when stimulated with
LPS for 24 hours [12]. Thus, the levels of TNF produced by
LPS-stimulated mTALH tubules were similar to concentrations
of exogenous TNF which were shown to affect mTALH func-
tion, and support the hypothesis that TNF can act as an
endogenous regulator of mTALH function.
It is important to recognize that as the hypotension associ-
ated with exposure to endotoxin progresses, renal blood flow is
increasingly compromised and may result in end organ damage.
Since the mTALH actively transports ions across its mem-
brane, this nephron segment is highly oxygen-dependent. As
the mTALH has a limited capacity for anaerobic metabolism,
this segment of the nephron can maintain functional integrity
only for short periods in the absence of oxygen [33]. Early
intervention with agents which would serve to attenuate the
induction of TNF following exposure to endotoxin may serve to
limit or delay renal damage. However, in cases of acute and
chronic inflammation, these effects may be manifested over a
longer duration of time. In either case, intervention subsequent
to TNF production, may have renal-protective effects.
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extracted and analyzed by Northern blot analysis using a radiolabeled
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[27—29], and transcription of the prostaglandin H synthase 2
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